Literature DB >> 28115516

Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.

Kunal N Karmali1, Donald M Lloyd-Jones2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28115516      PMCID： PMC5308879          DOI： 10.1161/HYPERTENSIONAHA.116.08249

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  48 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.

Authors:  Sidney C Smith; Rod Jackson; Thomas A Pearson; Valentin Fuster; Salim Yusuf; Ole Faergeman; David A Wood; Michael Alderman; John Horgan; Philip Home; Marilyn Hunn; Scott M Grundy
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

4.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.

Authors:  R S Vasan; M G Larson; E P Leip; W B Kannel; D Levy
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

5.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

6.  Risk stratification in hypertension: new insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

7.  Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; P W Wilson; D Levy
Journal:  Arch Intern Med       Date:  1999-10-11

8.  Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Authors:  L Ferrucci; C D Furberg; B W Penninx; M DiBari; J D Williamson; J M Guralnik; J G Chen; W B Applegate; M Pahor
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321
View more
  13 in total

1.  Initiation of antihypertensive therapy.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2018-02

Review 2.  Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research.

Authors:  Daniel T Lackland; Robert M Carey; Adriana B Conforto; Clive Rosendorff; Paul K Whelton; Philip B Gorelick
Journal:  Stroke       Date:  2018-02-21       Impact factor: 7.914

Review 3.  Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines.

Authors:  Wilbert S Aronow; William H Frishman
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

4.  The Role of Lifestyle Factors in Controlling Blood Pressure among Hypertensive Patients in Two Health Facilities in Urban Ghana: A Cross-Sectional Study.

Authors:  Emefa Modey Amoah; Darlene Esinam Okai; Adom Manu; Amos Laar; Joseph Akamah; Kwasi Torpey
Journal:  Int J Hypertens       Date:  2020-09-07       Impact factor: 2.420

5.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 6.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

7.  Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.

Authors:  Elizabeth do Espirito Santo Cestário; Letícia Aparecida Barufi Fernandes; Luiz Tadeu Giollo-Júnior; Jéssica Rodrigues Roma Uyemura; Camila Suemi Sato Matarucco; Manoel Idelfonso Paz Landim; Luciana Neves Cosenso-Martin; Lúcia Helena Bonalume Tácito; Heitor Moreno; José Fernando Vilela-Martin; Juan Carlos Yugar-Toledo
Journal:  Trials       Date:  2018-02-12       Impact factor: 2.279

8.  A Model for Risk Prediction of Cerebrovascular Disease Prevalence-Based on Community Residents Aged 40 and above in a City in China.

Authors:  Qin Zhu; Die Luo; Xiaojun Zhou; Xianxu Cai; Qi Li; Yuanan Lu; Jiayan Chen
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

Review 9.  Managing Hypertension in the elderly: What's new?

Authors:  Wilbert S Aronow
Journal:  Am J Prev Cardiol       Date:  2020-05-01

10.  Wholegrain Consumption and Risk Factors for Cardiorenal Metabolic Diseases in Chile: A Cross-Sectional Analysis of 2016-2017 Health National Survey.

Authors:  Fabian Lanuza; Raul Zamora-Ros; Nicole Hidalgo-Liberona; Cristina Andrés-Lacueva; Tomás Meroño
Journal:  Nutrients       Date:  2020-09-14       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.